(15046889), K. E. H., (15046892), X. W., (15046895), J. S. R., (15046898), D. J. L., (15046901), N. E. S., (15046904), W. J. F., . . . (15046970), M. E. Y. (2025). Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.